Is It Time to Rethink Standard Anticoagulation? Apixaban vs VKA in HeartMate 3 LVADs
Tania Ahuja, Clinical Assistant Professor, Assistant Director of Clinical Pharmacy and Clinical Pharmacotherapy Specialist, shared a post on X:
”Is it time to re-think anticoagulation for HeartMate3 (HM3) LVADs?
2 RCTs and 3 observational studies including 209 patients: 119 in the apixaban group and 90 in the VKA group demonstrating apixaban just as good as VKA and with less.”
Read the full article here.
Title: Efficacy and safety of apixaban versus vitamin K antagonists in patients with heartmate 3 fully magnetically levitated left ventricular assist device: a comprehensive meta-analysis
Authors: Andrea Tripoli, Miguel A. Samaniego, Norma N. Gamarra-Valverde, Shivraj Paneer Selvam, Edgardo Kaplinsky, Alejandro Barbagelata, Anna Mara Scandroglio, Juliana Giorgi
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Aug 10, 2025, 02:59What's Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One
-
Aug 8, 2025, 18:06Catch Up on Anticoagulation Forum Newsletter: Explore The Upcoming
-
Aug 8, 2025, 15:28Claudio Laudani: New Insights on P2Y12 Monotherapy in Antiplatelet Therapy
-
Aug 8, 2025, 11:59Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
-
Aug 8, 2025, 06:26Francisco López Romero-Salazar Shares A Closer Look at ROTEM and Thrombin Generation Assays
-
Aug 10, 2025, 04:39Sara García Barcenilla: High-Quality Care for People with Hemophilia and Congenital Bleeding Disorders
-
Aug 10, 2025, 01:12PROTECmo Study: Thrombocytopenia in VenoVenous ECMO Linked to High Bleeding Risk
-
Aug 9, 2025, 17:30Ayesha Butt: Role of Neutrophil Extracellular Traps in APS-Related Thrombosis
-
Aug 9, 2025, 17:06Mahmoud Ismayl: Meta-Analysis on Cerebral Embolic Protection in TAVR
-
Aug 9, 2025, 16:20Beyond the Standard: Individualized Approaches to Dual Antiplatelet Therapy Gain Attention
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025